155 related articles for article (PubMed ID: 11466685)
1. Infertility treatment after conservative management of borderline ovarian tumors.
Beiner ME; Gotlieb WH; Davidson B; Kopolovic J; Ben-Baruch G
Cancer; 2001 Jul; 92(2):320-5. PubMed ID: 11466685
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: a preliminary report.
Fasouliotis SJ; Davis O; Schattman G; Spandorfer SD; Kligman I; Rosenwaks Z
Fertil Steril; 2004 Sep; 82(3):568-72. PubMed ID: 15374697
[TBL] [Abstract][Full Text] [Related]
3. [Assisted reproductive technologies after conservative management of borderline or invasive ovarian tumours].
Fortin A; Hazout A; Thoury A; Alvès K; Bats AS; Dhainaut C; Madelenat P
Gynecol Obstet Fertil; 2005; 33(7-8):488-97. PubMed ID: 16019249
[TBL] [Abstract][Full Text] [Related]
4. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis and fertility after conservative treatment for ovarian tumors of limited malignity: review of 68 cases].
Camatte S; Rouzier R; Boccara-Dekeyser J; Pautier P; Pomel C; Lhomme C; Duvillard P; Castaigne D; Morice P
Gynecol Obstet Fertil; 2002; 30(7-8):583-91. PubMed ID: 12199041
[TBL] [Abstract][Full Text] [Related]
6. Conservatively treated borderline ovarian tumours, followed by IVF treatment: a case series.
Cabenda-Narain NE; Jansen FW; Dieben SW; Verburg HJ; Gaarenstroom KN
J Obstet Gynaecol; 2011 May; 31(4):327-9. PubMed ID: 21534756
[TBL] [Abstract][Full Text] [Related]
7. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
8. Outcome and reproductive function after conservative surgery for borderline ovarian tumors.
Morris RT; Gershenson DM; Silva EG; Follen M; Morris M; Wharton JT
Obstet Gynecol; 2000 Apr; 95(4):541-7. PubMed ID: 10725486
[TBL] [Abstract][Full Text] [Related]
9. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
10. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment.
Park CW; Yang KM; Kim HO; Hong SR; Kim TJ; Lim KT; Lee KH; Kang IS
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S134-8. PubMed ID: 17923740
[TBL] [Abstract][Full Text] [Related]
12. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
13. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
15. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
Marcickiewicz J; Brännström M
Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
[TBL] [Abstract][Full Text] [Related]
16. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
[TBL] [Abstract][Full Text] [Related]
17. Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary.
Uzan C; Kane A; Rey A; Gouy S; Duvillard P; Morice P
Ann Oncol; 2010 Jan; 21(1):55-60. PubMed ID: 19608617
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.
Franchi D; Boveri S; Radice D; Portuesi R; Zanagnolo V; Colombo N; Testa AC
Am J Obstet Gynecol; 2016 Dec; 215(6):756.e1-756.e9. PubMed ID: 27443811
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors.
Tinelli FG; Tinelli R; La Grotta F; Tinelli A; Cicinelli E; Schönauer MM
Acta Obstet Gynecol Scand; 2007; 86(1):81-7. PubMed ID: 17230294
[TBL] [Abstract][Full Text] [Related]
20. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
